Lyka Labs Intrinsic Value
Lyka Labs (LYKALABS) median intrinsic value is ₹57.78 from 3 valuation models (range ₹25–₹84), vs current price ₹61.27 — -5.7% downside (Trading Near Calculated Value), margin of safety -6.0%. Browse Lyka Labs financial data for revenue, profit, balance sheet and cash flow data.
LYKALABS Valuation Methods Summary — DCF, Graham Number & P/E
Lyka Labs intrinsic value across 3 models vs current price ₹61.27 — upside/downside and value range per method. For current market price and key ratios, visit Lyka Labs screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹57.78 | ₹52.00 - ₹63.56 | -5.7% | Book Value/Share: ₹28.89, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹84.44 | ₹76.00 - ₹92.88 | +37.8% | Revenue/Share: ₹42.22, P/S: 2.0x |
| Simple DCF (5Y) | dcf | ₹24.51 | ₹19.61 - ₹29.41 | -60.0% | CF Growth: 5.0%, Discount: 15% |
LYKALABS Intrinsic Value vs Market Price — All Valuation Models
Lyka Labs fair value range ₹25–₹84 vs current market price ₹61.27 across 3 valuation models. Also explore LYKALABS share price data to track price trends across different timeframes.
LYKALABS Intrinsic Value Analysis — Undervalued or Overvalued?
Lyka Labs median intrinsic value ₹57.78, current price ₹61.27 — Trading Near Calculated Value by 5.7%, margin of safety -6.0%.
What is the intrinsic value of LYKALABS?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Lyka Labs (LYKALABS) is ₹57.78 (median value). With the current market price of ₹61.27, this represents a -5.7% variance from our estimated fair value.
The valuation range spans from ₹24.51 to ₹84.44, indicating ₹24.51 - ₹84.44.
Is LYKALABS undervalued or overvalued?
Based on our multi-method analysis, Lyka Labs (LYKALABS) appears to be trading near calculated value by approximately 5.7%.
LYKALABS Financial Health — Key Ratios vs Industry Benchmarks
Lyka Labs financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.58 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -11.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -7.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.86x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
LYKALABS Cash Flow Quality — Operating & Free Cash Flow
Lyka Labs operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹2 Cr | ₹-4 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹2 Cr | ₹-3 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹9 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹79 Cr | ₹76 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹9 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |